The global biotechnology market reached a size of USD 761.5 Billion in 2024 and is projected to expand to USD 1,315.9 Billion by 2033, growing at a CAGR of 6.27% during the forecast period from 2025 to 2033. The market growth is driven by advancements in personalized medicine, genetic engineering innovations such as CRISPR-Cas9, and the rising demand for sustainable agriculture solutions. These developments fuel biotechnology applications across healthcare, agriculture, and environmental management, revolutionizing treatment approaches, crop improvements, and bioremediation. 

Study Assumption Years

• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Period: 2025-2033

Biotechnology Market Key Takeaways

• Market Size in 2024: USD 761.5 Billion
• Expected CAGR (2025-2033): 6.27%
• Forecast Period: 2025-2033
• Biotechnology uses live organisms and biological systems to develop innovative products across healthcare, agriculture, and environmental management.
• Genetic engineering breakthroughs, especially CRISPR-Cas9, enable precise gene editing with applications in medicine and agriculture.
• Personalized medicine is advancing due to genomic sequencing, allowing targeted therapies and biopharmaceutical development.
• Sustainable agriculture gains from biotechnology via genetically modified crops and biopesticides that reduce ecological impact.
• North America leads the market due to robust R&D infrastructure, regulatory frameworks, and strong investment in biotech innovation.

Sample Request Link: 

https://www.imarcgroup.com/biotechnology-market/requestsample

Market Growth Factors

Innovation in Genetic Engineering and Personalized Medicine

The biotechnology market growth is largely propelled by rapid advancements in genetic engineering, notably CRISPR-Cas9 technology, which facilitates precise genetic modifications. This technology enables medicine development for genetic disorders and cancers and engineering microbes for pharmaceuticals, thereby revolutionizing biopharmaceutical manufacturing. Additionally, personalized medicine, powered by genomic sequencing technologies, allows analysis of individual genetic codes to develop targeted therapies, increasing treatment efficacy and reducing side effects. The rise in chronic diseases further boosts demand for biopharmaceuticals and precision therapeutics, reinforcing the market expansion.

Escalating Demand for Sustainable Agriculture Solutions

Growth in the biotechnology market is strongly supported by the need for sustainable farming solutions driven by global population growth and limited cultivable land. Biotechnology contributes through genetically modified crops engineered for improved yield, pest resistance, and nutritional quality. Biopesticides derived from natural organisms are preferred over traditional chemicals due to lower environmental footprint. Innovations optimize plant traits, enhance crop resilience against climate change, and increase nutrient efficiency, collectively addressing food security and ecological sustainability challenges.

Integration of Bioinformatics and Environmental Biotechnology

The intersection of information technology with biotechnology, termed bioinformatics, is enhancing research and development efficiency by optimizing information-driven insights. Moreover, the establishment of bioremediation technologies and biofuels aligns with the growing global emphasis on environmental sustainability. These technological advancements expand biotechnology's role beyond healthcare and agriculture into environmental conservation and renewable energy sectors, driving further market growth by addressing critical ecological concerns.

Market Segmentation

By Product Type:

• Instruments: They form the foundation of advanced research and diagnostics, enabling precise analysis and experimentation.
• Reagents: Essential for fueling experimental processes, reagents facilitate accurate results and breakthroughs.
• Software and Services: Software provides data analysis, visualization, and integration solutions enhancing efficiency, while services include consulting, training, and technical support fostering collaboration.

By Technology:

• Nanobiotechnology: Combines nanoscale materials with biological systems, revolutionizing drug delivery, diagnostics, and therapies.
• Tissue Engineering and Regeneration: Develops novel methods to create functional tissues to address organ shortages and medical needs.
• DNA Sequencing: Enables comprehensive genomic analysis, guiding personalized medicine and disease understanding.
• Cell-Based Assays: Provides cellular behavior insights to aid drug development and toxicity testing.
• Fermentation: A key process in producing biofuels, pharmaceuticals, and enzymes.
• PCR Technology: Amplifies DNA, critical for diagnostics and genetic research.
• Chromatography: Separates biomolecules precisely, important in drug purification and analytical work.
• Others

By Application:

• Healthcare: The largest segment, driving innovations in diagnostics, treatment, and personalized medicine with breakthroughs such as gene editing and biomarker development.
• Food and Agriculture
• Natural Resources and Environment
• Industrial Processing
• Bioinformatics
• Others

By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa 

Regional Insights

North America commands the largest share in the global biotechnology market, attributed to its strong research and innovation ecosystem, robust R&D investments, and established regulatory frameworks. The region boasts collaborations among universities, research institutes, and biotech companies, accelerating technological advancements. The 2025 'Biotech Across America' roadshow in North Carolina highlighted its leadership in biopharma manufacturing and agricultural biotech innovations, emphasizing the sector's crucial role in national security and economic resilience.

Recent Developments & News

In 2025, key partnerships and investments have underscored the market's dynamic growth. In May 2025, Biogen and City Therapeutics partnered to develop RNA interference therapies targeting CNS diseases, combining platforms for systemic treatments. Also in May, Biocon Biologics launched a biosimilar to Stelara in Japan, expanding its biologics market footprint. April 2025 saw Novartis announce a USD 23 Billion investment to enhance US biotech facilities, including new research hubs and job creation. Amgen increased its Ohio manufacturing investment to USD 1.4 Billion, expanding its workforce. In March 2025, Roche opened an innovation center in Boston focusing on cardiovascular and metabolic diseases, integrating AI-driven drug discovery.

Key Players

• Amgen Inc.
• Biocon Limited
• Biogen Inc.
• F. Hoffmann-La Roche AG
• Genmab A/S
• Lonza Group AG
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Seagen Inc.
• Syngenta AG
• Vertex Pharmaceuticals Incorporated

Ask for Report Customization:

https://www.imarcgroup.com/request?type=report&id=5785&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302